Sanxin Medtec released its performance for the first half of the year, with a net profit attributable to the parent company of 115 million yuan, an increase of 8.35%

Sanxin Medtec released its semi-annual report for 2025, with operating revenue of 761 million yuan, a year-on-year increase of 10.83%; net profit attributable to the parent company was 115 million yuan, a year-on-year increase of 8.35%. The net profit excluding non-recurring gains and losses was 103 million yuan, a year-on-year increase of 9.26%. The basic earnings per share were 0.2207 yuan, and the company plans to distribute a cash dividend of 1 yuan for every 10 shares to all shareholders. The company continues to expand its market and improve performance through a full product chain layout and moat advantages